1. Home
  2. Labeler Index
  3. Advanz Pharma (us) Corp.
  4. 59212-146
  5. Product Images: Nuvaring

Product Images Nuvaring

View Photos of Packaging, Labels & Appearance

Table of Contents

  1. Figure 1 - nuvaring 01
  2. Figure 2 - nuvaring 01a
  3. Chemical Structure - nuvaring 02
  4. Figure 3 - nuvaring 03
  5. Figure 3 - nuvaring 04
  6. Figure 4 - nuvaring 05
  7. Figure A, Figure B, Figure C - nuvaring 06
  8. Figure D, Figure E - nuvaring 07
  9. Figure F - nuvaring 08
  10. Figure G - nuvaring 09
  11. Figure H - nuvaring 10
  12. Figure I - nuvaring 11
  13. Figure J - nuvaring 12
  14. Principle Display Panel - 3 Ring Pouch Carton - nuvaring 13

Product Label Images

The following 14 images provide visual information about the product associated with Nuvaring NDC 59212-146 by Advanz Pharma (us) Corp., such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.

Figure 1 - nuvaring 01

Figure 1 - nuvaring 01

Figure 2 - nuvaring 01a

Figure 2 - nuvaring 01a

Chemical Structure - nuvaring 02

Chemical Structure - nuvaring 02

Figure 3 - nuvaring 03

Figure 3 - nuvaring 03

Figure 3 - nuvaring 04

Figure 3 - nuvaring 04

This text appears to be describing different pregnancy rates and birth control methods. It mentions the rates of pregnancies per 100 women in a year, ranging from fewer than 1 to 85 or more. It also discusses various birth control methods such as implants, injections, intrauterine devices, sterilization, birth control pills, skin patch, vaginal ring, and methods like avoiding sex during fertile days, spermicide, and withdrawal.*

Figure 4 - nuvaring 05

Figure 4 - nuvaring 05

Figure A, Figure B, Figure C - nuvaring 06

Figure A, Figure B, Figure C - nuvaring 06

Figure D, Figure E - nuvaring 07

Figure D, Figure E - nuvaring 07

Figure F - nuvaring 08

Figure F - nuvaring 08

This text mentions medical terms related to female reproductive organs: uterus, vagina, and NuvaRing®. NuvaRing® is a contraceptive ring inserted into the vagina. It is used to prevent pregnancy by releasing hormones.*

Figure G - nuvaring 09

Figure G - nuvaring 09

Figure H - nuvaring 10

Figure H - nuvaring 10

Figure I - nuvaring 11

Figure I - nuvaring 11

Figure J - nuvaring 12

Figure J - nuvaring 12

Principle Display Panel - 3 Ring Pouch Carton - nuvaring 13

Principle Display Panel - 3 Ring Pouch Carton - nuvaring 13

This is a description for NuvaRing, a prescription vaginal ring for contraceptive use. It contains 0.120 mg/day of etonogestrel and 0.015 mg/day of ethinyl estradiol and is used for a 3-week period. Each ring contains active ingredients such as etonogestrel and ethinyl estradiol, along with excipients. The product should be stored refrigerated before dispensing and can then be stored for up to 4 months at room temperature. It is important to place an expiration date label on the product packaging when dispensing to the patient. NuvaRing is manufactured by Advanz Pharma (US) Corp and N.V. Organon in The Netherlands.*

* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.